Showing 1 - 4 results of 4 for search 'Dilan Paranagama', query time: 0.03s Refine Results
  1. 1
    Recruitment strategies and geographic representativeness for patient survey studies in rare diseases: Experience from the living with myeloproliferative neoplasms patient survey.

    Recruitment strategies and geographic representativeness for patient survey studies in rare diseases: Experience from the living with myeloproliferative neoplasms patient survey. by Jingbo Yu, Dilan Paranagama, Shreekant Parasuraman

    Published 2020-01-01
    Get full text
    Article
  2. 2
    Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data

    Are patients with high-risk polycythemia vera receiving cytoreductive medications? A retrospective analysis of real-world data by Dilan Paranagama, Philomena Colucci, Kristin A. Evans, Machaon Bonafede, Shreekant Parasuraman

    Published 2018-07-01
    Get full text
    Article
  3. 3
    Impact of Myeloproliferative neoplasms on patients’ employment status and work productivity in the United States: results from the living with MPNs survey

    Impact of Myeloproliferative neoplasms on patients’ employment status and work productivity in the United States: results from the living with MPNs survey by Jingbo Yu, Shreekant Parasuraman, Dilan Paranagama, Andrew Bai, Ahmad Naim, David Dubinski, Ruben Mesa

    Published 2018-04-01
    Get full text
    Article
  4. 4
    Cytoreductive treatment patterns among US veterans with polycythemia vera

    Cytoreductive treatment patterns among US veterans with polycythemia vera by Shreekant Parasuraman, Jingbo Yu, Dilan Paranagama, Sulena Shrestha, Li Wang, Onur Baser, Robyn Scherber

    Published 2018-05-01
    Get full text
    Article

Search Tools: